Log In
Reimbursement Policy: Bundling Guidelines for Diagnostic Radiopharmaceuticals and Contrast Materials
Effective October 1, 2024, Blue Cross and Blue Shield of North Carolina (Blue Cross NC) will apply a revision to the reimbursement policy for Bundling Guidelines for diagnostic radiopharmaceuticals and contrast materials. This revision is consistent with CMS guidelines.
Diagnostic radiopharmaceuticals and contrast materials billed by a facility or in a facility place of service (POS) will not be eligible for separate reimbursement, as they are considered incidental to the related imaging procedure. This policy revision will not apply to professionals in a non-facility setting, such as in an office. Please see the related Commercial (PDF) and Medicare (PDF) policy for more information.
This change will apply to Commercial, Inter-Plan Program (IPP) Host, State Health Plan, Federal Employee Program (FEP) and Senior Market Administration (SMA). This will not apply to IPP Home.
Blue Cross and Blue Shield of North Carolina does not discriminate on the basis of race, color, national origin, sex, age or disability in its health programs and activities. Learn more about our non-discrimination policy and no-cost services available to you.
Information in other languages: Español 中文 Tiếng Việt 한국어 Français العَرَبِيَّة Hmoob ру́сский Tagalog ગુજરાતી ភាសាខ្មែរ Deutsch हिन्दी ລາວ 日本語
© 2024 Blue Cross and Blue Shield of North Carolina. ®, SM Marks of the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield plans. All other marks and names are property of their respective owners. Blue Cross and Blue Shield of North Carolina is an independent licensee of the Blue Cross and Blue Shield Association.